Venture Certified
| 기술평가보증기업(기금) | 2008-07-18 ~ 2009-07-17 | 20080105144 | 2008-07-18 |
| 기술평가보증기업(기금) | 2009-08-31 ~ 2011-08-30 | 20090107869 | 2008-07-18 |
| 기술평가보증기업(기금) | 2011-08-31 ~ 2013-08-30 | 20110106117 | 2008-07-18 |
| 기술평가보증기업(기금) | 2013-08-31 ~ 2015-08-30 | 20130107818 | 2008-07-18 |
| 기술평가보증기업(기금) | 2015-08-31 ~ 2017-08-30 | 20150109254 | 2008-07-18 |
| 기술평가보증기업(기금) | 2017-08-31 ~ 2019-08-30 | 20170111646 | 2008-07-18 |
| 기술평가대출기업(중진공) | 2019-08-31 ~ 2021-08-30 | 20190402147 | 2008-07-18 |
| 혁신성장유형 | 2022-01-05 ~ 2025-01-04 | 20220105030009 | 2008-07-18 |
| 혁신성장유형 | 2025-01-05 ~ 2028-01-04 | 20250226030061 | 2008-07-18 |
Revenue CAGR +14.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 183B | 140B | 139B |
| Operating Profit | 7.6B | 11B | 0.7B |
| Net Profit | 3.6B | 3.5B | 2.7B |
| Total Assets | 110B | 105B | 100B |
| Total Liabilities | 69B | 68B | 66B |
| Total Equity | 40B | 37B | 33B |
▲ 30.8%
▲ 29.2%
▼ 0.9%
▼ 10.0%
▲ 1.9%
| Name | Position | Role |
|---|---|---|
| 남경수 | 대표이사 | 대표 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 수용성 밀크씨슬 및 그의 제조방법 | 주식회사 보고신약 | 1020220155494 | 2022-11-18 | 등록 |
| 수용성 옥타코사놀 및 이의 제조방법 | 주식회사 보고신약 | 1020220140219 | 2022-10-27 | 등록 |
| 수용성 코엔자임큐텐 및 이의 제조방법 | 주식회사 보고신약 | 1020220057751 | 2022-05-11 | 등록 |
| 수용성 밀크씨슬 및 이의 제조방법 | 주식회사 보고신약 | 1020220057750 | 2022-05-11 | 등록 |
| 누에번데기 추출물로부터 분리 정제된 에스트로겐 작용 물질을 함유하는 기능성 식품 | 주식회사 보고신약 | 1020110006697 | 2011-01-24 | 등록 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울특별시 송파구",
"ceo_name": "남경수",
"certificate": [
{
"cert_number": "20080105144",
"changes": "",
"disclosure_date": "2008-07-18",
"first_cert_date": "2008-07-18",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2008-07-18 ~ 2009-07-17"
},
{
"cert_number": "20090107869",
"changes": "",
"disclosure_date": "2009-08-31",
"first_cert_date": "2008-07-18",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2009-08-31 ~ 2011-08-30"
},
{
"cert_number": "20110106117",
"changes": "",
"disclosure_date": "2011-09-19",
"first_cert_date": "2008-07-18",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2011-08-31 ~ 2013-08-30"
},
{
"cert_number": "20130107818",
"changes": "",
"disclosure_date": "2013-07-31",
"first_cert_date": "2008-07-18",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2013-08-31 ~ 2015-08-30"
},
{
"cert_number": "20150109254",
"changes": "",
"disclosure_date": "2015-09-04",
"first_cert_date": "2008-07-18",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2015-08-31 ~ 2017-08-30"
},
{
"cert_number": "20170111646",
"changes": "",
"disclosure_date": "2017-09-29",
"first_cert_date": "2008-07-18",
"no": "6",
"type": "기술평가보증기업(기금)",
"valid_period": "2017-08-31 ~ 2019-08-30"
},
{
"cert_number": "20190402147",
"changes": "",
"disclosure_date": "2019-10-01",
"first_cert_date": "2008-07-18",
"no": "7",
"type": "기술평가대출기업(중진공)",
"valid_period": "2019-08-31 ~ 2021-08-30"
},
{
"cert_number": "20220105030009",
"changes": "",
"disclosure_date": "2022-01-05",
"first_cert_date": "2008-07-18",
"no": "8",
"type": "혁신성장유형",
"valid_period": "2022-01-05 ~ 2025-01-04"
},
{
"cert_number": "20250226030061",
"changes": "",
"disclosure_date": "2025-02-26",
"first_cert_date": "2008-07-18",
"no": "9",
"type": "혁신성장유형",
"valid_period": "2025-01-05 ~ 2028-01-04"
}
],
"company_name": "㈜보고신약",
"corp_no": "116511-*******",
"financials": {
"2022": {
"capital_stock": 910000000,
"cost_of_sales": 12307865000,
"current_assets": 4861318000,
"current_liabilities": 2805651000,
"gross_profit": 1587671000,
"net_income": 269834000,
"net_income_bs": 266007000,
"non_current_assets": 5099830000,
"non_current_liabilities": 3823455000,
"non_operating_expenses": 798164000,
"non_operating_income": 994081000,
"operating_profit": 73917000,
"revenue": 13895536000,
"sga_expenses": 1513754000,
"total_assets": 9961148000,
"total_equity": 3332042000,
"total_liabilities": 6629106000
},
"2023": {
"capital_stock": 910000000,
"cost_of_sales": 11318154000,
"current_assets": 5203871000,
"current_liabilities": 3671543000,
"gross_profit": 2694603000,
"net_income": 345791000,
"net_income_bs": 340758000,
"non_current_assets": 5257571000,
"non_current_liabilities": 3117099000,
"non_operating_expenses": 818609000,
"non_operating_income": 58155000,
"operating_profit": 1106245000,
"revenue": 14012757000,
"sga_expenses": 1588358000,
"total_assets": 10461442000,
"total_equity": 3672800000,
"total_liabilities": 6788642000
},
"2024": {
"capital_stock": 910000000,
"cost_of_sales": 15676204000,
"current_assets": 6069074000,
"current_liabilities": 3860543000,
"gross_profit": 2579369000,
"net_income": 358785000,
"net_income_bs": 349364000,
"non_current_assets": 4902811000,
"non_current_liabilities": 3089179000,
"non_operating_expenses": 473436000,
"non_operating_income": 69697000,
"operating_profit": 762524000,
"revenue": 18255573000,
"sga_expenses": 1816845000,
"total_assets": 10971885000,
"total_equity": 4022163000,
"total_liabilities": 6949722000
}
},
"industry": "기타 비알코올 음료 제조업",
"investment": [],
"main_products": "기능성드링크",
"phone": "02-786-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |